BofA/Merrill Lynch Upgrades Abbott Labs (ABT) to Buy

January 30, 2015 6:58 AM

BofA/Merrill Lynch upgraded Abbott Labs (NYSE: ABT) from Neutral to Buy with a price target of $52.00 (from $50.00).Analyst Bob ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found